Hemoglobin-Based Oxygen Carrier Microparticles: Synthesis, Properties, and In Vitro and In Vivo Investigations

被引:76
|
作者
Xiong, Yu [1 ]
Steffen, Axel [1 ]
Andreas, Kristin [4 ,5 ]
Mueller, Susanne [2 ,3 ]
Sternberg, Nadine [1 ]
Georgieva, Radostina [1 ]
Baeumler, Hans [1 ]
机构
[1] Charite, Inst Transfus Med, D-10117 Berlin, Germany
[2] Charite, Dept Expt Neurol, D-10117 Berlin, Germany
[3] Charite, Ctr Stroke Res Berlin, D-10117 Berlin, Germany
[4] Charite, Tissue Engn Lab, D-10117 Berlin, Germany
[5] Charite, Dept Rheumatol & Clin Immunol, Berlin Brandenburg Ctr Regenerat Therapies, D-10117 Berlin, Germany
关键词
BOVINE HEMOGLOBIN; BLOOD SUBSTITUTES; POLYMERIZED HEMOGLOBIN; PROTEIN ENCAPSULATION; MICROCAPSULES; TRIAL; METHEMOGLOBIN; MULTICENTER; PARTICLES; CAPSULES;
D O I
10.1021/bm301085x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Bovine hemoglobin microparticles (Hb-MPs) as suitable oxygen carriers are fabricated easily by three key steps: coprecipitation of Hb and CaCO3 to make Hb-CaCO3-microparticles (Hb-CaCO3-MPs), cross-linking by glutaraldehyde (GA) to polymerize the Hb and dissolution of CaCO3 template to obtain pure Hb-MPs. The Hb entrapment efficiency ranged from 8 to 50% corresponding to a hemoglobin quantity per Hb-MP of at least one-third of that in one erythrocyte. The Hb-MPs are spherical, with an average diameter of 3.2 mu m and high oxygen affinity. The methemoglobin level was increased after preparation, but can be reduced to less than 7% with ascorbic acid. Phagocytosis assays showed low immunogenicity of Hb-MPs if the particles were cross-linked with low concentration of GA and treated with sodium borohydride. Magnetite-loaded Hb-MPs circulated up to 4 days after intravenous application.
引用
收藏
页码:3292 / 3300
页数:9
相关论文
共 50 条
  • [21] Hemoglobin-based oxygen carriers
    Hess, John R.
    TRANSFUSION, 2024, 64 (06) : 959 - 962
  • [22] The hemoglobin-based oxygen carrier Hemolink™ does not affect human platelet activation and function in vitro.
    Leytin, V
    Mody, M
    Mazer, D
    Freedman, J
    BLOOD, 2001, 98 (11) : 61A - 61A
  • [23] Validation of MR in-vivo measurement of oxygen saturation after resuscitation with a hemoglobin-based oxygen carrier in a rabbit model
    Chan, FP
    Jahr, JS
    Driessen, B
    Daunt, DA
    Li, KCP
    ANESTHESIOLOGY, 2000, 93 (3A) : U154 - U154
  • [24] Hemoglobin-based oxygen carrier and trials to substitute red blood cells
    Smani, Y.
    Labrude, R.
    Vigneron, C.
    Faivre, B.
    TRANSFUSION CLINIQUE ET BIOLOGIQUE, 2007, 14 (05) : 464 - 473
  • [25] EVALUATION OF THE SAFETY AND TOLERANCE OF HEMOGLOBIN-BASED OXYGEN CARRIER-201
    MONK, T
    GOODNOUGH, L
    HUGHES, G
    JACOBS, E
    ANESTHESIOLOGY, 1995, 83 (3A) : A285 - A285
  • [26] Resuscitation with a hemoglobin-based oxygen carrier after severe brain trauma
    King, DR
    Cohn, S
    Proctor, K
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2004, 199 (03) : S45 - S45
  • [27] Resuscitation with a hemoglobin-based oxygen carrier after traumatic brain injury
    King, DR
    Cohn, SM
    Proctor, KG
    JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 2005, 59 (03): : 553 - 560
  • [28] A hemoglobin-based oxygen carrier sensitized Cisplatin based chemotherapy in hepatocellular carcinoma
    Qi, Xiang
    Wong, Bing L.
    Lau, Sze Hang
    Ng, Kevin Tak-Pan
    Kwok, Sui Yi
    Sun, Chris Kin-Wai
    Tzang, Fei Chuen
    Shao, Yan
    Li, Chang Xian
    Geng, Wei
    Ling, Chang Chun
    Ma, Yuen Yuen
    Liu, Xiao Bing
    Liu, Hui
    Liu, Jiang
    Yeung, Wai Ho
    Lo, Chung Mau
    Man, Kwan
    ONCOTARGET, 2017, 8 (49) : 85311 - 85325
  • [29] Hemoglobin-based oxygen carriers
    A Gerson Greenburg
    Hae Won Kim
    Critical Care, 8
  • [30] Hemoglobin-based oxygen carriers
    Stowell, CP
    CURRENT OPINION IN HEMATOLOGY, 2002, 9 (06) : 537 - 543